Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gorovits

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|October 27, 2019
Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial SamplingLiang Zhu, Ying Wang, Alison Joyce, et al.
Journal of Immunological Methods|August 11, 2019
Addressing soluble target interference in the development of a functional assay for the detection of neutralizing antibodies against a BCMA-CD3 bispecific antibodyYing Wang, Michael Luong, Crisanto Guadiz, et al.
The AAPS Journal|November 3, 2022
Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response MaturationAlison Joyce, Christopher Shea, Zhiping You, et al.
Bioanalysis|June 18, 2019
Bioanalytical assays in support of tanezumab developmental and reproductive toxicity studies: challenges and learningsSusan Hurst, Tracey Clark, Deborah Finco, et al.
The AAPS Journal|March 15, 2018
A Simple Approach to Determine a Curve Fitting Model with a Correct Weighting Function for Calibration Curves in Quantitative Ligand Binding AssaysYuhong Xiang, Jean Donley, Elena Seletskaia, et al.
The AAPS Journal|June 5, 2019
Anti-drug Antibody Assay Conditions Significantly Impact Assay Screen and Confirmatory Cut-PointsBoris Gorovits, Ying Wang, Liang Zhu, et al.
Bioanalysis|October 26, 2019
Bioanalysis of adeno-associated virus gene therapy therapeutics: regulatory expectationsBoris Gorovits, Jean-Claude Marshall, Justin Smith, et al.
The AAPS Journal|August 23, 2023
Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody MarstacimabJean Donley, Darshana Jani, Tong Zhu, et al.
The AAPS Journal|November 23, 2016
Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay CutpointSeema C Kumar, Jason A DelCarpini, Qiang Qu, et al.
Bioanalysis|April 18, 2019
Multiplexed immunoassay approach to characterize antidrug antibody like specific reactivitySheldon Leung, Corinna Fiorotti, Michael Bibik, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|October 27, 2019
Fit-for-Purpose Validation of a Ligand Binding Assay for Toxicokinetic Study Using Mouse Serial SamplingLiang Zhu, Ying Wang, Alison Joyce, et al.
Journal of Immunological Methods|August 11, 2019
Addressing soluble target interference in the development of a functional assay for the detection of neutralizing antibodies against a BCMA-CD3 bispecific antibodyYing Wang, Michael Luong, Crisanto Guadiz, et al.
The AAPS Journal|November 3, 2022
Determination of Anti-drug Antibody Affinity in Clinical Study Samples Provides a Tool for Evaluation of Immune Response MaturationAlison Joyce, Christopher Shea, Zhiping You, et al.
Bioanalysis|June 18, 2019
Bioanalytical assays in support of tanezumab developmental and reproductive toxicity studies: challenges and learningsSusan Hurst, Tracey Clark, Deborah Finco, et al.
The AAPS Journal|March 15, 2018
A Simple Approach to Determine a Curve Fitting Model with a Correct Weighting Function for Calibration Curves in Quantitative Ligand Binding AssaysYuhong Xiang, Jean Donley, Elena Seletskaia, et al.
The AAPS Journal|June 5, 2019
Anti-drug Antibody Assay Conditions Significantly Impact Assay Screen and Confirmatory Cut-PointsBoris Gorovits, Ying Wang, Liang Zhu, et al.
Bioanalysis|October 26, 2019
Bioanalysis of adeno-associated virus gene therapy therapeutics: regulatory expectationsBoris Gorovits, Jean-Claude Marshall, Justin Smith, et al.
The AAPS Journal|August 23, 2023
Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody MarstacimabJean Donley, Darshana Jani, Tong Zhu, et al.
The AAPS Journal|November 23, 2016
Mitigation of Pre-existing Antibodies to a Biotherapeutic in Non-clinical Species When Establishing Anti-drug Antibody Assay CutpointSeema C Kumar, Jason A DelCarpini, Qiang Qu, et al.
Bioanalysis|April 18, 2019
Multiplexed immunoassay approach to characterize antidrug antibody like specific reactivitySheldon Leung, Corinna Fiorotti, Michael Bibik, et al.
Pageof 8